Triple
T10527083
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Lewy body dementia |
E248332
|
entity |
| Predicate | hasPathology |
P22707
|
FINISHED |
| Object | cortical Lewy bodies |
E229729
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: cortical Lewy bodies | Statement: [Lewy body dementia, hasPathology, cortical Lewy bodies]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: cortical Lewy bodies Context triple: [Lewy body dementia, hasPathology, cortical Lewy bodies]
-
A.
Lewy bodies
chosen
Lewy bodies are abnormal aggregates of the protein alpha-synuclein that accumulate inside neurons and are characteristic of Parkinson’s disease and related neurodegenerative disorders.
-
B.
Lewy body dementia
Lewy body dementia is a progressive neurodegenerative disorder characterized by cognitive decline, visual hallucinations, fluctuating alertness, and Parkinsonian movement symptoms, caused by abnormal protein deposits called Lewy bodies in the brain.
-
C.
alpha-synuclein
Alpha-synuclein is a neuronal protein whose abnormal aggregation is a hallmark of Parkinson’s disease and related synucleinopathies.
-
D.
TDP-43 proteinopathy
TDP-43 proteinopathy is a neurodegenerative condition characterized by abnormal aggregation and mislocalization of the TDP-43 protein, commonly implicated in disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
-
E.
progressive supranuclear palsy
Progressive supranuclear palsy is a rare neurodegenerative movement disorder characterized by early postural instability, vertical gaze palsy, and cognitive and behavioral changes due to widespread tau pathology in the brain.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d381c5c7448190bec34bee7ec72bac |
completed | April 6, 2026, 9:49 a.m. |
| NER | Named-entity recognition | batch_69d509f5ec348190875c8c877e70ba4a |
completed | April 7, 2026, 1:43 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69d90e31350c8190a7493cdc33cc450a |
completed | April 10, 2026, 2:50 p.m. |
Created at: April 6, 2026, 12:29 p.m.